25 related articles for article (PubMed ID: 6164610)
1. Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone.
Ludlam CA; Allan N; Blandford RB; Dowdle R; Bentley NJ; Bloom AL
Thromb Haemost; 1981 Dec; 46(4):743-6. PubMed ID: 6460338
[TBL] [Abstract][Full Text] [Related]
2. Measurement of beta-thromboglobulin and platelet factor 4 to follow up patients with artificial heart valves.
Bellon JL; Castellanos C; Acevedo L; Amiral J
Semin Thromb Hemost; 1993; 19 Suppl 1():178-82. PubMed ID: 8362264
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting performance and thromboembolism after porcine xenograft cardiac valve replacement.
Geha AS; Hammond GL; Laks H; Stansel HC; Glenn WW
J Thorac Cardiovasc Surg; 1982 Mar; 83(3):377-84. PubMed ID: 7062749
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the need of long-term antithrombotic therapy in patients with porcine heterograft heart valve.
Cella G; Casonato A; Schivazappa L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):150-5. PubMed ID: 6164610
[TBL] [Abstract][Full Text] [Related]
6. Porcine valves: Hancock and Carpentier-Edwards aortic prostheses.
Fann JI; Miller DC
Semin Thorac Cardiovasc Surg; 1996 Jul; 8(3):259-68. PubMed ID: 8843517
[TBL] [Abstract][Full Text] [Related]
7. [Valvular bioprostheses and anticoagulation].
Chambaz IC; Nendaz M
Rev Med Suisse; 2008 Oct; 4(175):2198-202. PubMed ID: 19024573
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
Colli A; Verhoye JP; Leguerrier A; Gherli T
Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
[TBL] [Abstract][Full Text] [Related]
9. Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement?
Jamieson WR; Gudas VM; Burr LH; Janusz MT; Fradet GJ; Ling H; Germann E; Lichtenstein SV
Eur J Cardiothorac Surg; 2009 Jan; 35(1):104-10. PubMed ID: 19056294
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
Stein PD; Alpert JS; Copeland J; Dalen JE; Goldman S; Turpie AG
Chest; 1992 Oct; 102(4 Suppl):445S-455S. PubMed ID: 1395828
[No Abstract] [Full Text] [Related]
11. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts.
Stein PD; Kantrowitz A
Chest; 1989 Feb; 95(2 Suppl):107S-117S. PubMed ID: 2644093
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
